DLHC
DLH Holdings Corp.
DLHC trails on the overall score without a compensating advantage in the available component scores.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over DLHC overall, supported by stronger fundamentals.
DLHC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Stable | |
| Weak |
DLHC's cash flow is currently stable, but its revenue, profitability and balance sheet are under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
DLHC PE Valuation
DLHC has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
DLHC Forward outlook
There aren't enough analyst estimates for DLHC to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DLHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.48 | -563% |
| Q1 2026 | -$0.30 | -179% |
| Q4 2025 | -$0.07 | -116% |
| Q3 2025 | $0.10 | -80% |
| Q2 2025 | $0.32 | +88% |
| Q1 2025 | $0.38 | +81% |
| Q4 2024 | $0.44 | +214% |
| Q3 2024 | $0.51 | +410% |
DLHC has swung to a loss: it lost $1.48 per share over the past year, after a profit the year before.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
DLHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $44.2M | -47% |
| Q1 2026 | $59.3M | -34% |
| Q4 2025 | $68.9M | -24% |
| Q3 2025 | $81.2M | -16% |
| Q2 2025 | $83.3M | -17% |
| Q1 2025 | $89.2M | -12% |
| Q4 2024 | $90.8M | -7.2% |
| Q3 2024 | $96.4M | -5% |
DLHC's revenue has slid since its 2021 peak: $44M last quarter, down 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.9% | -13 points |
| Q1 2026 | -0.1% | -5.8 points |
| Q4 2025 | 2.1% | -4.1 points |
| Q3 2025 | 2.8% | -3.8 points |
| Q2 2025 | 4.5% | -1.2 points |
| Q1 2025 | 5.7% | -0.1 points |
| Q4 2024 | 6.2% | -0.8 points |
| Q3 2024 | 6.6% | +6.5 points |
DLHC has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over DLHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
DLHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.2M | -55% |
| Q1 2026 | $3.8M | -75% |
| Q4 2025 | -$4.8M | +$7.3M |
| Q3 2025 | $10.7M | -13% |
| Q2 2025 | $9.4M | +109% |
| Q1 2025 | $15.1M | +205% |
| Q4 2024 | -$12.1M | -347% |
| Q3 2024 | $12.2M | -24% |
DLHC has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
DLHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +43K shares |
| 3 years | +4.3% | +593K shares |
| 5 years | +6.1% | +838K shares |
| Available history | +11% | +1.5M shares |
DLHC has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $5,000 |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
DLHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 7.6x | High |
| Q1 2026 | 5.3x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.6x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 4.0x | Elevated |
| Q3 2024 | 3.6x | Elevated |
DLHC's net debt is about 7.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DLHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.0 | Neutral |
| Stochastic | 11.3 | Oversold |
DLHC's weekly RSI is 31 (neutral) and its Stochastic is 11 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
DLHC PE vs Industrials Sector
| Metric | DLHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DLHC has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
DLHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.80 | 7.9% below |
| 20 week MA | $4.32 | 19% below |
| 50 week MA | $5.17 | 32% below |
| 100 week MA | $5.39 | 35% below |
| 200 week MA | $8.53 | 59% below |
DLHC is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over DLHC on trend strength, trading above more of its moving averages.
DLHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.12 | $9.15 | +122% |
| 2021 | $9.15 | $18.0 | +97% |
| 2022 | $18.0 | $12.5 | -30% |
| 2023 | $12.5 | $15.8 | +26% |
| 2024 | $15.8 | $7.63 | -52% |
| 2025 | $7.63 | $5.65 | -26% |
| 2026 YTD | $5.65 | $3.50 | -38% |
DLHC's yearly returns have swung widely, from +122% in 2020 to −52% in 2024. It's down 38% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over DLHC on returns for 2026, with the stronger performance.